Carlson Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $361K | Buy |
2,029
+454
| +29% | +$80.7K | 0.02% | 86 |
|
|
2024
Q3 | $311K | Buy |
+1,575
| New | +$311K | 0.01% | 91 |
|
|
2024
Q1 | – | Sell |
-3,174
| Closed | -$492K | – | 103 |
|
|
2023
Q4 | $492K | Buy |
3,174
+1,127
| +55% | +$175K | 0.03% | 123 |
|
|
2023
Q3 | $305K | Sell |
2,047
-153
| -7% | -$22.8K | 0.02% | 132 |
|
|
2023
Q2 | $296K | Buy |
2,200
+117
| +6% | +$15.8K | 0.02% | 138 |
|
|
2023
Q1 | $332K | Sell |
2,083
-87
| -4% | -$13.9K | 0.02% | 124 |
|
|
2022
Q4 | $351K | Sell |
2,170
-389
| -15% | -$62.9K | 0.03% | 115 |
|
|
2022
Q3 | $343K | Buy |
2,559
+14
| +0.6% | +$1.88K | 0.03% | 108 |
|
|
2022
Q2 | $390K | Sell |
2,545
-177
| -7% | -$27.1K | 0.03% | 106 |
|
|
2022
Q1 | $441K | Buy |
2,722
+561
| +26% | +$90.9K | 0.04% | 106 |
|
|
2021
Q4 | $293K | Buy |
2,161
+21
| +1% | +$2.85K | 0.03% | 134 |
|
|
2021
Q3 | $231K | Buy |
2,140
+74
| +4% | +$7.99K | 0.02% | 150 |
|
|
2021
Q2 | $233K | Buy |
2,066
+39
| +2% | +$4.4K | 0.03% | 139 |
|
|
2021
Q1 | $219K | Buy |
+2,027
| New | +$219K | 0.04% | 136 |
|